Robot revolution: Single-Port surgery could mean faster recovery for chest patients
NCT ID NCT07255703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new single-port surgical robot, called SHURUI, for chest surgeries like removing lung tumors or mediastinal masses. About 40 adults aged 18-75 who need these surgeries will take part. The goal is to see if the robot is safe and works well, with hopes of less pain and quicker recovery compared to traditional methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINAL TUMOUR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital
Shatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill keep lung cancer from returning?
- Seeing Cancer's hidden markers: a new PET tracer could reveal who responds to targeted therapy
- Could a simpler nerve block keep blood sugar steady after lung surgery?
- Could a simple ventilation tweak calm lung surgery inflammation?
- Can a skin patch before surgery ease Post-Op pain?
- Smart patch and app aim to boost lung recovery after cancer surgery